Attached files
| file | filename |
|---|---|
| EX-10.38 - ROYALTY PURCHASE AGREEMENT - XOMA Corp | ex10_38.htm |
| EX-31.1 - CERTIFICATION OF STEVEN B. ENGLE - XOMA Corp | ex31_1.htm |
| EX-32.1 - CERTIFICATION OF STEVEN B. ENGLE - XOMA Corp | ex32_1.htm |
| EX-32.2 - CERTIFICATION OF FRED KURLAND - XOMA Corp | ex32_2.htm |
| EX-31.2 - CERTIFICATION OF FRED KURLAND - XOMA Corp | ex31_2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 2)
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2010
or
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from __________to__________
Commission File No. 0-14710
XOMA Ltd.
(Exact name of registrant as specified in its charter)
|
Bermuda
(State or other jurisdiction of incorporation or organization)
|
52-2154066
(I.R.S. Employer Identification No.)
|
|
2910 Seventh Street, Berkeley,
California 94710
(Address of principal executive offices, including zip code)
|
(510) 204-7200
(Telephone Number)
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act). (Check one):
|
Large accelerated filer o
|
Accelerated filer x
|
Non-accelerated filer o
(Do not check if a smaller reporting company)
|
Smaller reporting company o
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act of 1934). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
|
Class
|
Outstanding at October 28, 2010
|
|
|
Common Shares, U.S. $0.0075 par value
|
21,798,576
|
We are filing this Amendment No. 2 (this “Amendment”) to our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2010 (the “Form 10-Q”) for the sole purpose of re-filing Exhibit 10.38 thereto in order to respond to comments received from the staff of the Securities and Exchange Commission regarding a request for confidential treatment of certain portions of Exhibit 10.38. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are being filed as exhibits to the Form 10-Q.
Except as described above, no other changes have been made to the Form 10-Q. This Amendment does not modify or update the disclosures or financial statements in the Form 10-Q or otherwise reflect any events occurring after the original filing of the Form 10-Q. As a result, this Amendment should be read in conjunction with the Form 10-Q.
ITEM 6. EXHIBITS
|
Number
|
|
|
10.24C
|
Second Amendment to Agreement dated September 15, 2008, between XOMA (US) LLC and National Institute of Allergy and Infectious Diseases (previously filed)
|
|
10.38
|
Royalty Purchase Agreement, dated as of August 12, 2010, by and among XOMA CDRA LLC, XOMA (US) LLC, XOMA Ltd., the buyer named therein (with certain confidential information omitted, which omitted information is the subject of a confidential treatment request and has been filed separately with the Securities and Exchange Commission)
|
|
31.1
|
Certification of Steven B. Engle, filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2
|
Certification of Fred Kurland, filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1
|
Certification of Steven B. Engle, furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2
|
Certification of Fred Kurland, furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
99.1
|
Press Release dated November 4, 2010 (previously furnished)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
XOMA Ltd.
|
||
|
Date: April 13, 2011
|
By:
|
/s/ STEVEN B. ENGLE
|
|
Steven B. Engle
Chairman, Chief Executive Officer and President
(principal executive officer)
|
||
|
|
||
|
Date: April 13, 2011
|
By:
|
/s/ FRED KURLAND
|
|
Fred Kurland
Vice President, Finance and Chief Financial Officer
(principal financial officer and chief accounting officer)
|
||